EarningsQ4 2025 Earnings Report

Nektar Therapeutics (NKTR) Q4 2025 Earnings Report

0 Followers

MX:NKTR Q4 2025 EPS Results

Actual EPS-$32.36

Consensus EPS-$44.97

Beat/MissBeat by +$12.62

One Year Ago EPS$8.18

Actual Revenue$396.41M

Expected Revenue$185.24M

Beat/MissBeat by +$211.18M

YoY Revenue Growth-25.25%

QuarterQ4 2025

Date03/12/2026

TimeAfter Close

Conference CallThursday, March 12, 2026

MX:NKTR Upcoming Earnings

Nektar Therapeutics's next earnings date is estimated for November 5, 2026, based on past reporting schedules.

MX:NKTR Q4 2025 Earnings Call

0:00 / 0:00

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 05, 2026	2026 (Q3)	-38.16 / -	-33.993	―
Aug 13, 2026	2026 (Q2)	-35.83 / -22.36	-53.626	58.31% (+31.27)
May 07, 2026	2026 (Q1)	-28.76 / -33.08	-65.441	49.44% (+32.36)
Mar 12, 2026	2025 (Q4)	-44.97 / -32.36	8.18	-495.56% (-40.54)
Nov 06, 2025	2025 (Q3)	-48.81 / -33.99	-49.081	30.74% (+15.09)
Aug 07, 2025	2025 (Q2)	-55.04 / -53.63	-68.168	21.33% (+14.54)
May 08, 2025	2025 (Q1)	-46.61 / -65.44	-51.808	-26.32% (-13.63)
Mar 12, 2025	2024 (Q4)	-36.97 / 8.18	-59.988	113.64% (+68.17)
Nov 07, 2024	2024 (Q3)	-54.26 / -49.08	-65.441	25.00% (+16.36)
Aug 08, 2024	2024 (Q2)	-50.44 / -68.17	-73.622	7.41% (+5.45)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed